MedPath
NMPA Approval

Insulin Aspart 30 Injection

S20140058

August 8, 2019

S20140058

Drug Information

门冬胰岛素30注射液

诺和锐30

注射剂

100单位/毫升,3毫升/支(笔芯)

生物制品

August 8, 2019

August 7, 2024

Company Information

Applicant Company

Novo Nordisk A/S

Novo Alle, DK-2880 Bagsvaerd, Denmark

Manufacturing Company

Novo Nordisk A/S

Novo Alle, DK-2880 Bagsvaerd

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

门冬胰岛素30注射液 - NMPA 批准文号 | MedPath